Nashville’s News Channel 5 recently interviewed Clinical Research Associates, Inc. Medical Director Dr. Stephan Sharp to discuss the dangers posed by RSV both to children and adults, and about the vaccine clinical study. Read more about the RSV study and the need for a vaccine below.
NASHVILLE, Tenn. (WTVF) — RSV vaccine trials have been happening in Nashville for several months and researchers said they’re going well, but volunteers are still needed.
Clinical Research Associates in Nashville has been testing two RSV vaccines for the respiratory virus since September focusing on the 60 and older age group. Preliminary data from the trials are expected to be available in a year.
The vaccines are being created by Janssen. Doctors hope a vaccine for RSV would be a game-changer.
More than 200 volunteers enrolled in the local study. Researchers said many of them have tested positive for COVID-19 during the trials and others had RSV.
Medical Director Stephan Sharp said there’s a little less than three weeks left for people to enroll if they are interested in being a part of history.
“The numbers we’re shooting for are very high and we’re trying to get in as many people as we can,” said Sharp. “It’s one of those viruses that parents certainly know about. We mostly see it in the US at least in kids under the age of two. By the age of two or three practically every child has had it.”
Volunteers are asked to sign up by February 14. Anyone aged 60 or older can sign up for the clinical study on the vaccine. You can find details here or by calling Clinical Research Associates at 615-329-2222. Volunteers receive study-related care at no cost and compensation.